Caret - the Carotene and Retinol Efficacy Trial

Balmes, John R.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 5U01CA047989-08
• Application #: 2092819
• Study Section: Special Emphasis Panel (SRC (D2))
• Project Start: 1988-09-15
• Project End: 1997-02-28
• Budget Start: 1996-03-01
• Budget End: 1997-02-28
• Support Year: 8
• Fiscal Year: 1996

Institution

• Name: University of California San Francisco
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 073133571
• City: San Francisco
• State: CA
• Country: United States
• Zip Code: 94143

Publications

Cartmel, B; Dziura, J; Cullen, M R et al. (2005) Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET). Eur J Clin Nutr 59:1173-80

Barnhart, S; Keogh, J; Cullen, M R et al. (1997) The CARET asbestos-exposed cohort: baseline characteristics and comparison to other asbestos-exposed cohorts. Am J Ind Med 32:573-81

Brodkin, C A; McCullough, J; Stover, B et al. (1997) Lobe of origin and histologic type of lung cancer associated with asbestos exposure in the Carotene and Retinol Efficacy Trial (CARET). Am J Ind Med 32:582-91

Omenn, G S; Goodman, G E; Thornquist, M D et al. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-5